EntityQ5404506· pop 10· linked from 1,665 articles

ethylphenidate

Ethylphenidate (EPH) is a central nervous system (CNS) stimulant and a close analog of methylphenidate.

Key facts

Drug.Verifiedfields: changed
Drug.Watchedfields: changed
Drug.verifiedrevid: 432850456
Drug.IUPAC_name: (RS)-Ethyl 2-phenyl-2-piperidin-2-ylacetate
Drug.image: Ethylphenidate.svg
Drug.image_class: skin-invert-image
Drug.width: 225px
Drug.image2: Ethylphenidate-3D-ball-model.png
Drug.image_class2: bg-transparent
Drug.legal_AU: S8 (Controlled Drug)
Drug.legal_BR: F2
Drug.legal_CA: Schedule 3
Drug.legal_UK: Class B
Drug.legal_UK_comment: Temporary Class Drug
Drug.legal_DE: Anlage II
Drug.legal_UN: P II
Drug.routes_of_administration: By mouth, insufflation, inhalation, sublingual, rectal, intramuscular, intravenous
Drug.bioavailability: Variable

via Wikipedia infobox

Article

6 sections

Contents

Pharmacology
Pharmacokinetics
Pharmacodynamics
Legality
See also
References

Ethylphenidate (EPH) is a central nervous system (CNS) stimulant and a close analog of methylphenidate.

Ethylphenidate acts as a norepinephrine–dopamine reuptake inhibitor, meaning it effectively boosts the levels of the norepinephrine and dopamine neurotransmitters in the brain, by binding to, and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft.